The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted ...

The Federal Trade Commission (FTC) has sued the top three ... system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin ... the Federal Trade Commission alleged in ...

In late September, the Federal Trade Commission (FTC ... In its complaint, the FTC accuses these companies of inflating insulin prices and steering patients toward higher-cost insulin products ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic ... the Federal Trade Commission ...